Bullfrog AI Holdings, Inc. Common Stock (BFRG) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Healthcare Information Services 산업에서 운영. 본사 소재지는 Gaithersburg, MD, 미국. 현재 CEO는 Vininder Singh.
BFRG 을(를) 보유 IPO 날짜 2023-02-13, 4 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $10.71M.
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
